Clinical Trial Update: A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . [Phase 3]

View source ↗

Summary

A Phase 3 randomized, multicenter, double-blind trial evaluated the efficacy and safety of mycophenolate mofetil in interstitial cystitis and painful bladder sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 3 | Status: TERMINATED